Register|Generate Password|Dos and Don'ts of Demat Account
For Login related queries e-mail: emkayassist@emkayglobal.com
"Attention Investors
1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. 3. Pay 20% upfront margin of the transaction value to trade in cash market segment. 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. 6.Investor Charter 7.Disclosure of Complaints 8.COMPLAINTS / SCORES 9. Verify Nomination in Account, click on link (:: Central Depository Services (India) Limited :: )
.......... Issued in the interest of Investors"
Regenerate OTP
Please contact to emkayassist@emkayglobal.com
Please select Mobile No and Email Id for OTP
Customer Guest
Login | Register
Login | Register|Forgot password?
Accretion Pharmaceuticals Limitedÿhas Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of I...more...
Accretion Pharmaceuticals Limited has informed the Exchange about Investor Presentationmore...
Accretion Pharmaceuticals Limited has informed the Exchange regarding a press release dated May 15 2026 titled Company Delivers Robust Performance in...more...
Accretion Pharmaceuticals Limited has informed the Exchange regarding Change in Auditors of the company.more...
Accretion Pharmaceuticals Limited has informed the Exchange regarding Appointment of Ms. Bandana Kumari as HR Manager of the company w.e.f. May 08 20...more...
Accretion Pharmaceuticals Limited has submitted to the Exchange the financial results for the period ended March 31 2026.more...
Structural Digital Database compliance certificate for year ended on 31.03.2026more...
Accretion Pharmaceuticals Limited has informed the Exchange regarding Confirmation on Non-Applicability of SEBI Circular on Large Corporates...more...
As of March 2026 73.52% is owned by Indian Promoters and 26.48% by Public. Top five Promoters holding highest number of shares of Accretion Pharma. c...more...
Significant movement in price has been observed in Accretion Pharmaceuticals Limited. The Exchange in order to ensure that investors have la...more...
Accretion Pharmaceuticals Limited has informed regarding Non-Applicability of the Regulation 27(2) of the SEBI (Listing Obligations and Disclosure Re...more...
Accretion Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations 2018more...
Accretion Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Re...more...
Accretion Pharmaceuticals Limited has informed the Exchange about Schedule of meetmore...
The Exchange has sought clarification from Accretion Pharmaceuticals Limited for the quarter ended 30-Sep-2025 with respect to Regulation 33...more...
As of December 2025 73.52% is owned by Indian Promoters and 26.48% by Public. Top five Promoters holding highest number of shares of Accretion Pharma...more...
Accretion Pharmaceuticals Limited has informed the Exchange about Action(s) taken or orders passedmore...
Accretion Pharmaceuticals Limited has informed regarding Submission of the Compliance Report on Corporate Governance for the Q3 FY 2025-26more...
BOARD MEETINGS Company Name : Majestic Research Date : 30-06-2026